Search results: Sage Journals

Restricted accessResearch articleFirst published June, 2026

Effects of Preoperative Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss After Bariatric Surgery

Mona Abdel-Bary, Andrea Brody, Po-Jen Yang [...]

Bariatric Surgical Practice and Patient Care

Open accessResearch articleFirst published 2026

Use of semaglutide and tirzepatide among people with multiple sclerosis

Amber Salter, Alexis Novak, Samantha Lancia [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published July, 2023

Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults

Rahul S. Dadwani, Wen Wan, M. Reza Skandari [...]

MDM Policy & Practice

Open accessBrief reportFirst published November, 2023

Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication

Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone [...]

Diabetes & Vascular Disease Research

Restricted accessResearch articleFirst published December, 2025

GLP-1 Receptor Agonist Use Is Associated With Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth

John A. Damianos, Thomas W. Fredrick, Mauricio F. Jin [...]

Foregut: The Journal of the American Foregut Society

Restricted accessResearch articleFirst published October, 2024

GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review,Meta-analysis,and Trial Sequential Analysis

Mustafa Kilickap, Volkan Kozluca, Türkan Seda Tan [...]

Angiology

Restricted accessResearch articleFirst published December, 2020

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

Vishnu Priya Pulipati, Venkatesh Ravi, Priyanjali Pulipati

European Journal of Preventive Cardiology

Restricted accessReview articleFirst published December, 2025

Management of Diabetic Kidney Disease

Usha Ayyagari

International Journal of Clinical Metabolism and Diabetes

Restricted accessResearch articleFirst published September, 2020

GLP1R Single-Nucleotide Polymorphisms rs3765467 and rs10305492 Affect β Cell Insulin Secretory Capacity and Apoptosis Through GLP-1

Weizheng Li, Pengzhou Li, Rao Li [...]

DNA and Cell Biology

Open accessReview articleFirst published 2026

Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis

Ikramulhaq Patel, Yin-He Chai, Zi-Qi Wang [...]

Therapeutic Advances in Endocrinology and Metabolism

Restricted accessResearch articleFirst published June, 2026

Effects of Preoperative Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss After Bariatric Surgery

Mona Abdel-Bary, Andrea Brody, Po-Jen Yang [...]

Bariatric Surgical Practice and Patient Care

Open accessResearch articleFirst published 2026

Use of semaglutide and tirzepatide among people with multiple sclerosis

Amber Salter, Alexis Novak, Samantha Lancia [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published July, 2023

Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults

Rahul S. Dadwani, Wen Wan, M. Reza Skandari [...]

MDM Policy & Practice

Open accessBrief reportFirst published November, 2023

Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication

Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone [...]

Diabetes & Vascular Disease Research

Restricted accessResearch articleFirst published December, 2025

GLP-1 Receptor Agonist Use Is Associated With Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth

John A. Damianos, Thomas W. Fredrick, Mauricio F. Jin [...]

Foregut: The Journal of the American Foregut Society

Restricted accessResearch articleFirst published October, 2024

GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review,Meta-analysis,and Trial Sequential Analysis

Mustafa Kilickap, Volkan Kozluca, Türkan Seda Tan [...]

Angiology

Restricted accessResearch articleFirst published December, 2020

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

Vishnu Priya Pulipati, Venkatesh Ravi, Priyanjali Pulipati

European Journal of Preventive Cardiology

Restricted accessReview articleFirst published December, 2025

Management of Diabetic Kidney Disease

Usha Ayyagari

International Journal of Clinical Metabolism and Diabetes

Restricted accessResearch articleFirst published September, 2020

GLP1R Single-Nucleotide Polymorphisms rs3765467 and rs10305492 Affect β Cell Insulin Secretory Capacity and Apoptosis Through GLP-1

Weizheng Li, Pengzhou Li, Rao Li [...]

DNA and Cell Biology

Open accessReview articleFirst published 2026

Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis

Ikramulhaq Patel, Yin-He Chai, Zi-Qi Wang [...]

Therapeutic Advances in Endocrinology and Metabolism